Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Frank C Kuo
Affiliation
ORCID
Career Start Year
1988
Papers
93
H Index
44
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
34638128
A germinal center-associated microenvironmental signature reflects malignant phenotype and outcome of DLBCL.
Blood advances
2022
31837959
Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial.
Lancet Haematol
2020
31855703
Next-generation sequencing informs diagnosis and identifies unexpected therapeutic targets in lung squamous cell carcinomas.
Lung Cancer
2020
32188490
Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma.
Genome Medicine
2020
31305863
Premalignant Clonal Hematopoietic Proliferations.
American Journal of Clinical Pathology
2019
30573040
Next generation sequencing in hematolymphoid neoplasia.
Seminars in Hematology
2019
30767667
The Distribution Volume of <sup>18</sup>F-Albumin as a Potential Biomarker of Antiangiogenic Treatment Efficacy.
Cancer Biother Radiopharm
2019
31141600
Introduction.
American Journal of Clinical Pathology
2019
30842135
Granular cell tumour in male breast mimicking breast carcinoma.
BMJ Case Reports
2019
31310240
Avoiding peripheral nerve injury in arterial interventions.
Diagnostic and Interventional Radiology
2019
31309983
Germline Predisposition to Hematolymphoid Neoplasia.
American Journal of Clinical Pathology
2019
29724895
High <i>NPM1</i>-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML.
Blood
2018
29467336
Frameshift events predict anti-PD-1/L1 response in head and neck cancer.
JCI Insight
2018
29326119
Association of mutations with morphological dysplasia in acute myeloid leukemia without 2016 WHO Classification-defined cytogenetic abnormalities.
Haematologica
2018
29274134
A distinct immunophenotype identifies a subset of NPM1-mutated AML with TET2 or IDH1/2 mutations and improved outcome.
American Journal of Hematology
2018
27863258
Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing.
J Mol Diagn
2017
28557599
Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.
2017
28600338
The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practice.
Blood
2017
28384399
Molecular Analysis of Genetic Markers for Non-Hodgkin Lymphomas.
Current Protocols in Human Genetics
2017
28370403
NPM1 mutation but not RUNX1 mutation or multilineage dysplasia defines a prognostic subgroup within de novo acute myeloid leukemia lacking recurrent cytogenetic abnormalities in the revised 2016 WHO classification.
American Journal of Hematology
2017
28446434
Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias.
Blood
2017
28407280
Coil-assisted retrograde transvenous obliteration and partial splenic artery embolization for hepatic encephalopathy.
Hepatology
2017
28472420
Determination of VH Family Usage in B-Cell Malignancies via the BIOMED-2 IGH PCR Clonality Assay.
American Journal of Clinical Pathology
2017
29296824
Systematic <i>STAT3</i> sequencing in patients with unexplained cytopenias identifies unsuspected large granular lymphocytic leukemia.
Blood Adv
2017
27241017
Detection of activating MAP2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variant.
Leukemia and Lymphoma
2017
28075487
Molecular Analysis of Gene Rearrangements and Mutations in Acute Leukemias and Myeloid Neoplasms.
Current Protocols in Human Genetics
2017
28297627
Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology.
Journal of Clinical Oncology
2017
28054397
Conventional cytogenetics for myeloid neoplasms in the era of next-generation-sequencing.
Am J Hematol
2017
27959687
Case 37-2016. An 86-Year-Old Woman with Leukocytosis and Splenomegaly.
N Engl J Med
2016
27339098
Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.
Journal of Molecular Diagnostics
2016
26913631
Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva.
JAMA Oncology
2016
26829311
KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
J Thorac Oncol
2016
27523973
Molecular Pathology: Prognostic and Diagnostic Genomic Markers for Myeloid Neoplasms.
Surgical Pathology Clinics
2016
27882345
Institutional implementation of clinical tumor profiling on an unselected cancer population.
JCI Insight
2016
25231023
Targeted genomic analysis of Müllerian adenosarcoma.
Journal of Pathology
2015
25933675
Next-generation sequencing-based panel testing for myeloid neoplasms.
Current Hematologic Malignancy Reports
2015
27148573
Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case.
Cold Spring Harb Mol Case Stud
2015
27148563
Myeloid neoplasm demonstrating a STAT5B-RARA rearrangement and genetic alterations associated with all-trans retinoic acid resistance identified by a custom next-generation sequencing assay.
Cold Spring Harb Mol Case Stud
2015
26175414
Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia.
Cancer Cell
2015
26407235
A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
Blood Cancer J
2015
24843823
Pathology informatics fellowship training: Focus on molecular pathology.
J Pathol Inform
2014
25441687
Ewing sarcoma mimicking atypical carcinoid tumor: detection of unexpected genomic alterations demonstrates the use of next generation sequencing as a diagnostic tool.
Cancer genetics
2014
25426837
Age-related clonal hematopoiesis associated with adverse outcomes.
N Engl J Med
2014
24909865
Simultaneous ECG-gated PET imaging of multiple mice.
Nucl Med Biol
2014
25191621
The ongoing evolution of the core curriculum of a clinical fellowship in pathology informatics.
J Pathol Inform
2014
24984190
Immuno-PET imaging of tumor endothelial marker 8 (TEM8).
Mol Pharm
2014
25171694
Computational pathology: an emerging definition.
Arch Pathol Lab Med
2014
25157968
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
J Mol Diagn
2014
24238397
Effects of and satisfaction with short message service reminders for patient medication adherence: a randomized controlled study.
BMC Med Inform Decis Mak
2013
23024889
Different tracks for pathology informatics fellowship training: Experiences of and input from trainees in a large multisite fellowship program.
J Pathol Inform
2012
1 - 50 of 93
Column Actions
Search
Recommended Authors
Collaborators
Daniel J DeAngelo
Dana-Farber Cancer Institute
Co-authored papers
8
Laura E MacConaill
Co-authored papers
8
Donna Neuberg
Co-authored papers
6
Christopher J Gibson
Co-authored papers
6
Robert Coleman Lindsley
Co-authored papers
6
David P Steensma
Novartis Institutes for BioMedical Research
Co-authored papers
5
Michael J Kluk
Co-authored papers
5
Stuart H Orkin
Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School
Co-authored papers
4
Bruce Levy
Geisinger Commonwealth School of Medicine
Co-authored papers
4
Azra H Ligon
Co-authored papers
4
Richard M Stone
Dana Farber Cancer Institute
Co-authored papers
4
Matthew Meyerson
Broad Institute
Co-authored papers
3
Benjamin L Ebert
Co-authored papers
3
Matthew Ducar
Co-authored papers
3
Timothy A Graubert
Massachusetts General Hospital
Co-authored papers
3
Peter L Choyke
National Cancer Institute, National Institutes of Health
Co-authored papers
3
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers
3
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Co-authored papers
3
Michael J Becich
University of Pittsburgh School of Medicine
Co-authored papers
2
Aaron R Thorner
Co-authored papers
2
Jerome Ritz
Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital
Co-authored papers
2
Philip W Kantoff
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Brenton G Mar
Co-authored papers
2
Paul Van Hummelen
Co-authored papers
2
David M Weinstock
Merck & Co.
Co-authored papers
2
John M Higgins
Co-authored papers
2
Christopher P Crum
Co-authored papers
2
Todd R Golub
Broad Institute of MIT and Harvard
Co-authored papers
2
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers
2
Craig H Mermel
Co-authored papers
2
1 - 30